Neonatal Respiratory Distress Panel
Use
The Neonatal Respiratory Distress Panel is designed for individuals who have a clinical or suspected diagnosis of Neonatal Respiratory Distress syndrome. It is particularly relevant for newborns, both preterm and full-term, who present with respiratory symptoms within 24 hours of birth. The test aims to aid differential diagnosis between genetic and developmental causes, specifically surfactant deficiencies.
Special Instructions
All testing must be ordered by a qualified healthcare provider. A completed online order or paper test requisition form and labeled specimen is required to initiate testing. New York State Genetic Testing Healthcare Provider Statement is needed if the test is conducted in New York and it is not NY state approved.
Limitations
The test has been developed and validated by PreventionGenetics following CAP and CLIA regulations. However, it has not been cleared or approved by the FDA. The limitations primarily include the technical and analytical constraints inherent in NGS-based testing, such as potential false negatives due to low coverage or complex genomic regions not adequately assessed by NGS or CNV analysis.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided